POST Online Media Lite Edition



 

Health : Page 42

Women in England will be able to access cheaper hormone replacement therapy for menopause

February 21, 2023
From 1 April 2023, women prescribed hormone replacement therapy (HRT), the main treatment for menopause symptoms, will have access to a new scheme enabling access to a year’s worth of menopause prescription items for the cost of 2 single prescription charges (currently £18.70).

Egypt to examine travelers from Guinea after Marburg outbreak

February 20, 2023
Egypt’s quarantine teams will examine all passengers and crews traveling from Equatorial Guinea to Egyptian airports and entry points after the Marburg virus killed nine in the first outbreak in Equatorial Guinea.

FDA accepts Valneva’s Chikungunya vaccine license application for priority review

February 20, 2023
Valneva SE announced that the U.S. Food and Drug Administration (FDA) has completed a filing review of its Biologics License Application for Valneva’s single-shot chikungunya vaccine candidate VLA1553 and has determined that the application is sufficiently complete to permit a substantive review.

Renexxion Ireland and Dr. Falk Pharma initiated Phase II study of naronapride in patients with gastroparesis

February 16, 2023
Renexxion Ireland, a biopharmaceutical company, announces that the first patient has been treated in Europe with naronapride, a potential best-in-class pan-GI prokinetic, in a Phase IIb trial for gastroparesis conducted by Dr. Falk Pharma.

Survivors of Utah's eugenic sterilization program still alive in 2023

February 15, 2023
At least 830 men, women and children were coercively sterilized in Utah, approximately 54 of whom may still be alive.

Male contraceptive pill prototype stops sperm swimming

February 15, 2023
An on-demand, non-hormonal male contraceptive pill may be a real possibility say scientists who have found a cell pathway, or switch, that stops sperm from being able to swim.

WHO convenes urgent meeting over outbreak of Marburg virus, one of world's deadliest diseases

February 14, 2023
The World Health Organization (WHO) convened an urgent meeting Tuesday amid an outbreak of one of the deadliest diseases known to man in Africa.

Eli Lilly and IABL to ensure patient access to high-quality affordable insulin in Bangladesh

February 14, 2023
Eli Lilly and Company will supply its active pharmaceutical ingredient (API) for human insulin at a reduced price to International Agencies Bangladesh (IABL) in an effort to increase patient access and improve affordability for high quality insulin for nearly one million people living with diabetes in Bangladesh by 2030.

Hawaii: Low levels of PFAS detected in Makakilo Well

February 14, 2023
Low levels of Perfluoropentanoic acid (PFPeA) has been detected in water samples collected at Makakilo Well, which is part of the Honolulu Board of Water Supply’s (BWS) Ewa-Waianae water system.

WHO urges immediate, targeted measles vaccination in Europe

February 11, 2023
The World Health Organization\'s (WHO) Regional Office for Europe on Friday urged countries in the region to immediately develop targeted measles vaccination catch-up strategies.

Risk of bird flu infection in humans is low, says WHO

February 9, 2023
The World Health Organization (WHO) on Wednesday cleared out that the risk of H5N1 avian influenza infection in humans is too low, according to WHO Director-General, Tedros Adhanom, in response to recent reports of several H5N1 cases in mammals including sea lions, otters, minks and foxes.

Pierre Fabre to commercialize and distribute first approved allogeneic T-cell immunotherapy in Europe

February 9, 2023
Pierre Fabre and Atara Biotherapeutics, Inc. announced the transfer of the European Commission (EC) marketing authorization (MA) for EBVALLO (tabelecleucel) for patients with relapsed or refractory Epstein–Barr virus positive post–transplant lymphoproliferative disease (EBV+ PTLD) from Atara to Pierre Fabre.
<< 41 42 43 44 45 ... >>